- CARDIOLOGY CONSULT DEEMED UNNECESSARY. // Clinician Reviews;Dec2007, Vol. 17 Issue 12, p28
A reprint of the article "Cardiology Consult Deemed Unnecessary," which appeared in the "Medical Malpractice Verdicts, Settlements and Experts" journal. This case is about the internist's negligence to refer a patient to a cardiologist. The patient is in his early 40s who had been seen by the...
- Meta-analysis of Flecainide Safety in Patients with Supraventricular Arrhythmias. Wehling, Martin // Drug Research / Arzneimittel-Forschung (Editio Cantor Verlag fur;Jul2002, Vol. 52 Issue 7, p507
Flecainide (CAS 54143-55-4) has been associated with increased mortality in patients with ventricular dysfunction and arrhythmias. It is a potent suppressant of supraventricular arrhythmias, but safety data for use in this condition are rare. A meta-analysis was performed including 122...
- Flecainide. // Reactions Weekly;1/22/2011, Issue 1335, p21
The article describes the case of a man with a history of cardiac arrhythmias, who presented with red patches on his legs, arms and trunk while receiving flecainide.
- Is there a genetic factor in flecainide toxicity? Beckmann, J.; Hertrampf, R.; Gundert-Remy, U.; Mikus, G.; Gross, A.S.; Eichelbaum, M. // BMJ: British Medical Journal (International Edition);11/19/88, Vol. 297 Issue 6659, p1316
Examines the toxicity of flecainide. Association of cardiac arrhythmias treatment with adverse drug reactions; Elimination of flecainide by urinary excretion and hepatic metabolism; Analysis on the kinetics of renal excretion of flecainide.
- Implantable Devices Reduce the Risks of Sudden Cardiac Arrest. // Focus on Healthy Aging;Dec2012, Vol. 15 Issue 12, p1
The article reports on the results of a study which found that implantable cardioverter defibrillators (ICDs) can help reduce the risk of sudden cardia arrest due to ventricular fibrillation. It offers information on ICDs which regularly monitors the heart's rhythm and will restore normal rhythm...
- Contrasting effects of flecainide on atrial arrhythmia in wildtype and RyR2-P2328S mice. Salvage, S. C.; King, J. H.; Chandrasekharan, K. H.; Matthews, H. R.; Guzadhur, L.; Huang, C. L.; Fraser, J. A. // Proceedings of the Physiological Society;2014, p59P
An abstract of the article "Contrasting effects of flecainide on atrial arrhythmia in wildtype and RyR2-P2328S mice" by S.C. Salvage, J. H. King, K. H. Chandrasekharan, H. R. Matthews, L. Guzadhur, C. L. Huang and J. A. Fraser is presented.
- Chronic Kidney Disease and Mortality in Implantable Cardioverter-Defibrillator Recipients. Cheema, Aamir; Singh, Tejwant; Kanwar, Manreet; Chilukuri, Karuna; Maria, Viqar; Saleem, Fareena; Johnson, Katrina; Frank, John; Pires, Luis; Hassan, Sohail // Cardiology Research & Practice;Jan2010, p1
Incidence of sudden cardiac death (SCD) in end-stage renal disease (ESRD) remains high. Limited data is available about whether implantable cardioverter-defibrillators (ICDs) can prevent arrhythmic death in patients with chronic kidney disease (CKD). The purpose of this retrospective study was...
- Treating critical supraventricular and ventricular arrhythmias. Trappe, Hans-Joachim // Journal of Emergencies, Trauma & Shock;Apr2010, Vol. 3 Issue 2, p143
Atrial fibrillation (AF), atrial flutter, AV-nodal reentry tachycardia with rapid ventricular response, atrial ectopic tachycardia and preexcitation syndromes combined with AF or ventricular tachyarrhythmias (VTA) are typical arrhythmias in intensive care patients (pts). Most frequently, the...
- Defibrillators Save Lives. // Medical Update;Apr99, Vol. 22 Issue 10, p2
Evaluates the easy-to-use defibrillators, which stop life-threatening heart arrhythmias and save lives. People using defibrillators.